2 hours Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Receives Average Recommendation of “Moderate Buy” from Analysts MarketBeat
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) has been assigned an average rating of “Moderate Buy” from the thirteen ratings firms that are currently covering the firm, MarketBeat reports. One equities research analyst has rated the…
Nasdaq 100 · Pharmaceuticals · Science